Cronos (CRON) Shares Outstanding (Weighted Average) (2016 - 2026)
Cronos (CRON) recorded quarterly Shares Outstanding (Weighted Average) of $379.4 million in Q1 2026, down 1.07% quarter-over-quarter from $383.5 million in Q4 2025, and down 0.94% on a YoY basis from $383.0 million in Q1 2025.
Cronos (CRON) Shares Outstanding (Weighted Average) (2016 - 2026) Analysis & Trends
Cronos' Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $379.4 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 0.94% year-over-year to $379.4 million; the TTM figure through Mar 2026 stood at $379.4 million (down 0.94% YoY), while the FY2025 annual figure was $383.5 million, changed 0.37% from the prior year.
- Shares Outstanding (Weighted Average) was $379.4 million for Q1 2026 at Cronos, down from $383.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $385.3 million in Q2 2025 to a low of $375.0 million in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $380.2 million across 5 years, with a median of $381.0 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) gained 3.31% in 2022, then slipped 0.94% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $377.0 million in 2022, then increased by 1.06% to $381.0 million in 2023, then grew by 0.29% to $382.1 million in 2024, then increased by 0.37% to $383.5 million in 2025, then decreased by 1.07% to $379.4 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $379.4 million (Q1 2026), $383.5 million (Q4 2025), and $385.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn | 379.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 379.37 Mn |
| Dec 31, 2025 | 383.47 Mn |
| Jun 30, 2025 | 385.31 Mn |
| Mar 31, 2025 | 382.96 Mn |
| Dec 31, 2024 | 382.06 Mn |
| Sep 30, 2024 | 382.29 Mn |
| Dec 31, 2023 | 380.96 Mn |
| Dec 31, 2022 | 376.96 Mn |
| Sep 30, 2022 | 378.11 Mn |
| Jun 30, 2022 | 375.53 Mn |
| Mar 31, 2022 | 375.02 Mn |
| Dec 31, 2021 | 370.39 Mn |
| Sep 30, 2021 | 372.46 Mn |
| Jun 30, 2021 | 367.39 Mn |
| Mar 31, 2021 | 363.01 Mn |
| Dec 31, 2020 | 351.58 Mn |
| Sep 30, 2020 | 350.29 Mn |
| Jun 30, 2020 | 348.95 Mn |
| Mar 31, 2020 | 348.82 Mn |
| Sep 30, 2019 | 338.96 Mn |